| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/21/2011 | US20110091587 Phase ii detoxification and antioxidant activity |
| 04/21/2011 | US20110091524 Biomarkers for sensitivity to anti-igf1r therapy |
| 04/21/2011 | US20110091502 Human parvovirus: humink parvovirus |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091497 Method For Identifying and Validating Dominant T Helper Cell Epitopes Using An HLA-DM-Assisted Class II Binding Assay |
| 04/21/2011 | US20110091482 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| 04/21/2011 | US20110091481 Biomarkers for predicting response to immunosuppressive therapy |
| 04/21/2011 | US20110091474 Compositions and Methods For Diagnosing and Treating Diabetic Micro Vascular Complications |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091457 Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy |
| 04/21/2011 | US20110091439 Cosmetic use of acid ceramidase type proteins |
| 04/21/2011 | US20110091429 Methods for Enhancing Stem Cell Engraftment During Transplantation |
| 04/21/2011 | US20110091422 Use of Genetic Markers for Identifying the Response to Interferon Treatment in Multiple Sclerosis Patients |
| 04/21/2011 | US20110091421 Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases |
| 04/21/2011 | US20110091387 Methods and compositions for reducing skin damage |
| 04/21/2011 | US20110091377 Biomarkers for melanoma |
| 04/21/2011 | US20110091376 Catatonic steroid antimicrobial diagnostic, detection, screening and imaging methods |
| 04/21/2011 | US20110091081 Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin |
| 04/21/2011 | US20110088312 Biodiesel production method |
| 04/21/2011 | DE102010025496A1 Verfahren zur Detektion von Genveränderungen, insbesondere Mutationen Method for the detection of gene mutations, particularly mutations |
| 04/21/2011 | DE102009048473A1 Method for the detection of microorganisms in a bath with a water-based varnish, comprises transferring a sample in the bath, with a salt in order to coagulate the solid of the varnish and separating the coagulate from the liquid |
| 04/21/2011 | DE102009048199A1 Verfahren zur Bestimmung von Faktor XIII mit Hilfe von Referenzmaterial auf Plasmabasis A method for the determination of factor XIII using reference material plasma-based |
| 04/21/2011 | DE102009048198A1 Verfahren zur Bestimmung von Faktor XIII mittels NAD(P)H-Analoga A method for the determination of factor XIII using NAD (P) H-analogues |
| 04/21/2011 | CA2811817A1 Epigenetic dna enrichment |
| 04/21/2011 | CA2780464A1 Acute kidney injury risk testing |
| 04/21/2011 | CA2777800A1 Biomarkers and methods for measuring and monitoring inflammatory disease activity |
| 04/21/2011 | CA2777699A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | CA2777690A1 Mass spectrometry quantitation of p450 protein isoforms in hepatocytes |
| 04/21/2011 | CA2777600A1 Macronutrient sensitivity |
| 04/21/2011 | CA2777501A1 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr |
| 04/21/2011 | CA2777446A1 Methods and compositions for amplifying target sequences from nucleic acid samples |
| 04/21/2011 | CA2777369A1 Quantification of ir-a and ir-b for tumor classification |
| 04/21/2011 | CA2777249A1 Manipulation of flavonoid biosynthetic pathway |
| 04/21/2011 | CA2775613A1 Protein detection via nanoreporters |
| 04/21/2011 | CA2772789A1 Bare single-layer graphene membrane having a nanopore enabling high-sensitivity molecular detection and analysis |
| 04/20/2011 | EP2312317A2 Fluorescent detection system and dye set for use therewith |
| 04/20/2011 | EP2312316A1 Anti-EPHA2 antibodies as a cancer diagnostic |
| 04/20/2011 | EP2312024A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity |
| 04/20/2011 | EP2311995A1 Methods of using IL-21 |
| 04/20/2011 | EP2311994A1 Compositions and methods for preparing short RNA molecules and other nucleic acids |
| 04/20/2011 | EP2311993A2 Method of detecting and quantifying hepatitis C virus |
| 04/20/2011 | EP2311992A1 Method for rapid detection and identification of bioagents |
| 04/20/2011 | EP2311986A1 Method of diagnosing esophageal cancer |
| 04/20/2011 | EP2311985A1 Sirna for treating esophageal cancer |
| 04/20/2011 | EP2311984A1 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| 04/20/2011 | EP2311983A1 Method of treating bladder cancer using siRNA |
| 04/20/2011 | EP2311982A1 Method of sequencing nucleic acids |
| 04/20/2011 | EP2311981A1 Methods for diagnosing ischemia |
| 04/20/2011 | EP2311980A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311979A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/20/2011 | EP2311978A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311977A1 Method for predicting responsiveness of a patient to a chemoradiation treatment |
| 04/20/2011 | EP2311976A1 Method for Streptococcus Pneumoniae diagnosis and serotyping |
| 04/20/2011 | EP2311975A1 Electrophoretic biomolecules separation device |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311957A1 Antigens from granulocytic Ehrlichia |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311939A1 Polypeptide immobilization |
| 04/20/2011 | EP2311937A1 Method of growing bacteria to deliver bioactive compounds to the intestine of ruminants |
| 04/20/2011 | EP2311934A2 Rapid detection of replicating cells |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311862A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311861A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311860A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311855A2 Bacillus licheniformis YvnA negative strain |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311848A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 04/20/2011 | EP2311530A2 Mammalian genes involved in infection |
| 04/20/2011 | EP2311468A1 Gene overexpressed in cancer |
| 04/20/2011 | EP2310857A2 Electrophoretically enhanced detection of analytes on a solid support |
| 04/20/2011 | EP2310851A2 Method and apparatus for determining the yield of at least one component |
| 04/20/2011 | EP2310850A1 A diagnostic method |
| 04/20/2011 | EP2310536A1 Method for evaluating the virulence of pathogenic biphasic bacteria |
| 04/20/2011 | EP2310535A2 Fast assignment of adequate chemotherapy with platinum based drugs for cancer patients based on the identification of constitutional brcal mutations |
| 04/20/2011 | EP2310534A1 Base-detecting pore |
| 04/20/2011 | EP2310533A2 Genetic markers associated with degenerative disc disease and uses thereof |
| 04/20/2011 | EP2310532A2 Methods of promoting weight loss and associated arrays |
| 04/20/2011 | EP2310531A1 Markers for detection of legionella pneumophila strains |
| 04/20/2011 | EP2310530A2 Method for diagnosing and predicting cerebellar ataxia |
| 04/20/2011 | EP2310529A2 Microvesicle-based compositions and methods |
| 04/20/2011 | EP2310528A1 A genetic marker test for brachyspina and fertility in cattle |
| 04/20/2011 | EP2310527A1 Improved lysis and reverse transcription for mrna quantification |
| 04/20/2011 | EP2310526A2 Compositions for the detection and treatment of colorectal cancer |
| 04/20/2011 | EP2310525A1 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof |
| 04/20/2011 | EP2310524A1 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids |
| 04/20/2011 | EP2310522A1 Real time polymerase chain reaction process using a universal detection system |
| 04/20/2011 | EP2310402A1 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 04/20/2011 | EP2310401A1 Universal methylation profiling methods |
| 04/20/2011 | EP1910566B1 Methods of detecting viability-associated molecules |
| 04/20/2011 | EP1899487B1 Gfats as modifiers of the axin pathway and methods of use |
| 04/20/2011 | EP1640455B1 Fluorescent protein |